Streetbeat News

Stock Prices

CHEA

Chenghe Acquisition Co. (NASDAQ:CHEA) shares surged after shareholders approved a merger with Taiwan Color Optics, Inc., leading to a name change to 'Semilux Ltd.' The stock experienced heavy trading volume, significantly above its 100-day average.

Portfolio Pulse from Erica Kollmann

February 05, 2024 | 6:26 pm

CHTR

Charter Communications' stock trades lower following downgrades by JP Morgan and Barclays. JP Morgan downgraded CHTR from Overweight to Neutral and reduced its price target from $445 to $370. Barclays also cut its price target from $325 to $280.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 6:22 pm

IDXX

IDEXX Laboratories Inc (NASDAQ:IDXX) shares rose after reporting Q4 2023 earnings that exceeded expectations, with adjusted EPS of $2.32 against a consensus of $2.12, and sales of $901.60 million versus $891.25 million expected. Sales grew 9% year-over-year, driven by a 10% growth in Companion Animal Group (CAG). The company forecasts FY 2024 sales between $3.93 billion and $4.04 billion, with a profit range of $10.84 to $11.33 per share, against a consensus of $11. William Blair highlighted IDEXX's resilience and positive long-term outlook, supported by increased pet ownership and the upcoming launch of InVue Dx in late 2024.

Portfolio Pulse from Vandana Singh

February 05, 2024 | 6:21 pm

AAPL

FOX

FOXA

META

Apple Inc released its Apple Vision Pro headsets, marking a significant advancement in virtual reality. A 2016 episode of 'The Simpsons,' which aired on Fox Corporation's FOX, seemingly predicted the widespread use of VR headsets in public. The episode has gone viral on X, highlighting the show's history of predicting future events. Apple's Vision Pro, priced at $3,499, has seen strong pre-orders, with analysts predicting success but questioning the timeline and price point. Meta Platforms' Oculus Quest 3 is mentioned as a lower-priced competitor.

Portfolio Pulse from Chris Katje

February 05, 2024 | 6:19 pm

SLB

Schlumberger (NYSE:SLB) has seen a surge in options activity, with a notable division between bullish and bearish sentiments among deep-pocketed investors. The activity includes 14 extraordinary options trades, with an almost equal split between puts and calls, indicating a price window expectation of $42.5 to $62.5. Current trading volume and a slight price decrease are observed, alongside expert ratings that generally maintain a positive outlook on SLB, with target prices ranging up to $77.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 6:15 pm

AMAT

Applied Materials (NASDAQ:AMAT) has seen a notable bullish sentiment in its options trading, with 53% of traders being bullish and 46% bearish. The trading activity suggests a target price range of $150 to $240. Significant trades include both calls and puts, with a higher volume and value in calls. Applied Materials, a leading semiconductor equipment manufacturer, has a current stock price of $168.44, with an RSI indicating it may be overbought. Analyst ratings vary, with an average target price of $166.67, and specific ratings from Barclays (Underweight, $140), Raymond James (Outperform, $180), and Cantor Fitzgerald (Neutral, $180).

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 6:15 pm

ARGX

JNJ

Johnson & Johnson announced positive results from Phase 3 VIVACITY and Phase 2 DAHLIAS studies of nipocalimab for treating generalized myasthenia gravis and Sjögren’s disease, respectively. Nipocalimab showed significant clinical effects, marking it as a new contender in the FcRn antagonist category, competing with Argenx SE's Vyvgart Hytrulo. Vyvgart Hytrulo, approved by the FDA in June 2023 for gMG, is expected to generate $2.5 billion in revenue. The news impacted JNJ and ARGX stock prices.

Portfolio Pulse from Vandana Singh

February 05, 2024 | 6:10 pm

MODN

Model N (NYSE:MODN) is scheduled to release its quarterly earnings report on February 6, 2024, with analysts expecting an EPS of $0.29. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat resulting in a 15.5% drop. Shares are currently trading at $27.58, down 33.03% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 6:02 pm

USNA

Usana Health Sciences (NYSE:USNA) is scheduled to release its quarterly earnings report on February 6, 2024, with analysts estimating an EPS of $0.52. The company's past earnings performance shows a mix of misses and beats, with the stock price reacting accordingly. Shares have been trading at $47.23 as of February 2, reflecting a 21.77% decline over the last 52 weeks. Investors are likely focused on both the reported earnings and the company's future guidance.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 6:02 pm

WERN

Werner Enterprises (NASDAQ:WERN) is scheduled to release its quarterly earnings report on 2024-02-06, with analysts estimating an EPS of $0.43. The company's past earnings performance shows a mix of misses and beats against estimates, with the share price reacting variably. Shares are currently trading at $39.95, down 19.07% over the last 52 weeks. Investors are looking for positive guidance for the next quarter beyond the EPS figure.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 6:01 pm